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Abstract
Aims—To estimate short-term mortality rates for individuals with type 1 or type 2 diabetes 
diagnosed before age 20 years from the SEARCH for Diabetes in Youth study.
Methods—We included 8358 individuals newly-diagnosed with type 1 (n=6840) or type 2 (n= 
1518) diabetes from 1/1/2002–12/31/2008. We searched the National Death Index through 
12/31/2010. We calculated standardized mortality ratios (SMRs) as observed divided by expected 
numbers of deaths based on age, sex, and race for the comparable US population in the geographic 
areas of the SEARCH study.
Results—Mean age at diabetes diagnosis was 10.7 years. During 44,893 person-years (PY) of 
observation (median follow-up=5.3 years), 41 individuals died (91.3 deaths/100,000 PY); 26 with 
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type 1 (70.6 deaths/100,000 PY) and 15 with type 2 (185.6 deaths/100,000 PY) diabetes. The 
expected mortality rate was 70.9 deaths/100,000 PY. The overall SMR (95% CI) was 1.3 (1.0, 1.8) 
and was high among individuals with type 2 diabetes 2.4 (1.3, 3.9), females 2.2 (1.3, 3.3), 15–19 
year olds 2.7 (1.7–4.0), and non-Hispanic blacks 2.1 (1.2, 3.4).
Conclusions—Compared to the state populations of similar age, sex, and race, our results show 
excess mortality in individuals with type 2 diabetes, females, older youth, and non-Hispanic 
blacks. We did not observe excess short-term mortality in individuals with type 1 diabetes. Studies 
of longer-term mortality in individuals with youth-onset diabetes are warranted.
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1. Introduction
Population-based studies in the US and territories,1–4 as well as other countries 5–13 have 
reported increased mortality for individuals with youth-onset type 1 diabetes compared to 
the general population, with standardized mortality ratios (SMRs) varying from 1.7 to 12.9 
5, 8
. Although few studies have evaluated mortality risk among individuals with youth-onset 
type 2 diabetes, it has been suggested that their mortality experience is worse than the 
general population and worse than those with youth-onset type 1 diabetes.7, 14
There is a paucity of data from contemporary populations in the US that can be used to 
identify people with youth-onset diabetes and evaluate their mortality risk. Most published 
studies have been limited to persons with type 1 diabetes. Further, few studies have 
examined cause-specific mortality among youth-onset type 2 diabetes. Using data from the 
SEARCH for Diabetes in Youth (SEARCH) study, we sought to estimate all-cause and 
cause-specific mortality in individuals with incident type 1 and type 2 diabetes diagnosed 
before 20 years of age (“youth-onset”) and to determine if the short-term mortality 
experience among SEARCH study participants differs from that of the comparable US 
population in the geographic areas of the SEARCH study.
2. Participants
SEARCH is a multicenter, population-based observational study of youth with incident 
diabetes who are followed longitudinally. A detailed description of study methods has been 
published.15 In brief, incident cases of physician-diagnosed diabetes in individuals aged <20 
years were identified beginning in 2002. Diabetes type is based on physician report around 
the time of diabetes and categorized as type 1 (including type 1, type 1a, or type 1b) and 
type 2 diabetes. Cases were ascertained from geographically defined populations at sites in 
Ohio, Colorado, South Carolina and Washington, among enrollees in one health plan in 
California (Kaiser Permanente Southern California), and among Indian Health Service 
beneficiaries from American Indian populations in Arizona and New Mexico. Cases were 
identified through networks of pediatricians and endocrinologists, other healthcare 
providers, hospitals, community health centers, and health plans.Eligible cases were 
registered anonymously with the coordinating center at the Wake Forest School of Medicine. 
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Case ascertainment has been >90% for both type 1 and type 2 diabetes for the duration of 
the study.15, 16
Local institutional review boards with jurisdiction over local study populations approved the 
study.
3. Materials and Methods
3.1 Mortality ascertainment
Vital status (living, deceased, unknown) and underlying and contributing causes of death 
were determined from linkages of all registered diabetes cases with the National Death 
Index (NDI) Plus database 17 from the date of diabetes diagnosis through 12/31/2010 unless 
cases were known to be alive on or after that date. Records where cases were known to be 
deceased were submitted to the NDI to obtain cause of death. NDI records were searched for 
all years for which vital status could not be confirmed. Deaths were verified by matching 
name, social security number (if available), date of birth, and sex. Death certificates and 
reports of deaths by immediate family members or healthcare providers were also 
considered definitive evidence of death.
Cause of death was derived from the NDI file and classified per International Classification 
Diseases, Tenth Revision (ICD-10). “Underlying cause of death” was used for cause-specific 
mortality. “Contributing cause of death” was used to identify deaths where diabetes was a 
significant condition contributing to death but not the underlying cause.
All 9213 individuals with incident type 1 or type 2 diabetes diagnosed between 1/1/2002 and 
12/31/2008 were eligible for mortality surveillance. We excluded 855 (9.3%) cases because 
their vital status was unknown and we did not have sufficient individual-level data for NDI 
linkage, leaving 8358 for mortality surveillance. The excluded cases were older at diagnosis, 
more likely to have type 2 than type 1 diabetes and to be non-Hispanic black or of unknown 
race/ethnicity compared to cases who were known alive or whose data were submitted to the 
NDI.
3.2 Statistical Analysis
Person-years (PY) of follow-up were calculated from date of diabetes diagnosis to either 
12/31/2010 or date of death, whichever occurred first. Age-, sex-, and race-standardized 
mortality rates were calculated using respective US state populations of the SEARCH study 
sites. Standardized mortality ratios (SMRs) were calculated as observed numbers of deaths 
in the SEARCH study divided by expected numbers of deaths based on age, sex, and race 
distributions for comparable US state populations of the study sites. For each year, we 
obtained population sizes and deaths in the corresponding US state populations from the 
Centers for Disease Control and Prevention (CDC) Wide-ranging Online Data for 
Epidemiologic Research (WONDER) online tool, which contains mortality and population 
counts for all US counties.18 Poisson regression was used to model death rates and calculate 
95% confidence intervals (CIs). Cause-specific mortality rates were not calculated because 
the numbers of deaths were too small for reliable estimates. Statistical analyses were 
performed using SAS software, version 9.3 (SAS Institute, Cary, NC).
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4. Results
Demographic characteristics of the 8358 SEARCH cases stratified by diabetes type are 
shown in Table 1. Follow-up time was similar among those with type 1 and type 2 diabetes.
During a median follow-up of 5.3 years (44,893 PY of observation), 41 deaths occurred 
(crude rate of 91.3 deaths/100,000 PY); 26 with type 1 (70.6 deaths/100,000 PY) and 15 
with type 2 diabetes (185.6 deaths/100,000 PY) (Table 2). The expected mortality rate was 
70.9 deaths/100,000 PY. Mortality for all groups combined was slightly higher than that of 
the comparable age-, sex-, and race-specific US state populations of the SEARCH study 
sites (SMR=1.3, 95% CI=1.0, 1.8), and was not statistically significant (p=0.08) (Figure 1). 
Mean (SD) age at death among individuals with type 1 and type 2 diabetes was 15.2 (4.9) 
and 20.0 (3.5) years, respectively. The crude mortality rate was higher for type 2 versus type 
1 diabetes. Compared to the US state populations, mortality in the SEARCH study was 
significantly higher than expected for individuals with type 2 diabetes (SMR=2.4, 95% 
CI=1.3, 3.9; p=0.001) but not for individuals with type 1 diabetes (SMR=1.1, 95% CI=0.7, 
1.6; p=0.84) (Figure 1). Females had higher mortality rates than males, and non-Hispanic 
Blacks and Hispanics had higher mortality rates than non-Hispanic whites. Individuals aged 
15–19 years at the time of death had the highest mortality rates compared to other age 
groups (Table 2). No deaths occurred among the 320 non-Hispanic whites with type 2 
diabetes (data not shown). Compared to the US state populations, mortality in the SEARCH 
study was significantly higher than expected for females (SMR=2.2, 95% CI=1.3, 3.3; 
p<0.001), non-Hispanic blacks (SMR=2.1, 95% CI=1.2, 3.4; p=0.004) and those aged 15–19 
years (SMR=2.7, 95% CI=1.7, 4.0; p<0.001) at the time of death or end of follow-up (Figure 
1).
Among decedents with type 1 diabetes, diabetes was the most frequent underlying cause of 
death followed by accidental injury and intentional self-harm (Table 3). Diabetes was listed 
as the contributing cause of death for 2 of the 26 deaths among individuals with type 1 
diabetes. Using the underlying or contributing cause of death due to diabetes, 50% of deaths 
among those with type 1 diabetes were related to their diabetes. Among decedents with type 
2 diabetes, the leading underlying cause of death was attributed to transport/motor vehicle 
accidents followed by accidental poisoning and intentional self-harm. Among individuals 
with type 2 diabetes, diabetes was not listed as contributing cause of death for any of the 
deaths but it was the underlying cause of death for 1 individual.
5. Discussion
In the SEARCH study, mortality for both types of diabetes together did not differ 
significantly from the comparable general US population in the geographic areas of the 
SEARCH study. However, compared to the general population, mortality was two-fold 
higher among those with type 2 diabetes, females, non-Hispanic Blacks, and those aged 15–
19 years at the time of death.
We identified 41 deaths during 44,893 person-years (91.3 deaths/100,000 PY) of observation 
over a median follow-up of 5.3 years; 26 deaths occurred in youth-onset type 1 diabetes 
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(70.6 deaths/100,000 PY) and 15 deaths occurred in youth-onset type 2 diabetes (185.6 
deaths/100,000 PY). The mortality rates we observed were substantially lower than what has 
been reported in other studies in the US 1, 19 and many other countries.10 However, few 
studies have reported on short-term mortality risk in youth-onset diabetes and comparisons 
of our findings to previous studies should be made with caution, due to differences in 
methods, study populations (including type of diabetes, age at diagnosis, diabetes duration, 
and historical versus contemporary cohorts), and the background population mortality. 
During 7.8 years of follow-up in the Chicago Diabetes Registry of 1238 individuals with 
diabetes onset before age 18 between 1985–2000, 30 individuals were reported to have died 
(250 deaths/100,000 PY).1 In the population-based Western Australia Children’s Diabetes 
Database, mortality among individuals with type 1 diabetes diagnosed before age 18 
between 1987–2011 was 74.5 deaths/100,000 PY during 7.6 years of follow-up.8 The lower 
mortality rates seen in the Western Australia Children’s Database and the SEARCH cohort 
could be due to a shorter duration of diabetes as well as the focus on more contemporary 
cohorts, which may have benefited from advances in diabetes treatment.
After a median 5.3 years of follow-up, we found that the crude mortality rate was higher for 
individuals with type 2 versus type 1 diabetes. Further, mortality for youth-onset type 2 
diabetes was higher than expected compared to the similar age, sex, and race state 
populations of the SEARCH study sites. Several studies have suggested that youth-onset 
type 2 diabetes is associated with more severe chronic diabetes complications and greater 
mortality.7, 20–22 Over a median 21 years of follow-up in the Royal Prince Alfred Hospital 
Diabetes Clinical Database in Australia, the adjusted hazard ratio for mortality was two-fold 
higher in type 2 versus type 1 diabetes (diabetes onset between ages 15–30 years).7
Mortality was higher in females compared to males in the SEARCH study and higher than 
expected in females compared with the general population (SMR=2.2; 95% CI: 1.3, 3.3). 
Similarly, the Western Australian Children’s Diabetes Database study found that mortality 
for females with type 1 diabetes was 10 times that of the general population, while no 
statistically significant elevated mortality risk was observed in males 8. Similar observations 
have been reported from studies conducted in Japan 23, Europe 6, and the US;19 however, 
some studies have observed higher mortality in males compared to females.24 The higher 
SMR among females may reflect the death rate in the general population for this age group 
where young males have a two-fold higher death rate than females.
We found that mortality in non-Hispanic blacks in the SEARCH study was 2.1 times higher 
than the mortality in the similar age, sex, and race state populations of the SEARCH study 
sites. These findings are supported by other studies in the US and territories.1, 25, 26 We 
previously reported that a substantial proportion of non-Hispanic black youth with diabetes 
have adverse socioeconomic profiles,27 which may be associated with barriers to care and 
contribute to the increased mortality.
There are several limitations to our study. We could not conduct detailed cause-specific 
mortality analyses due to the small number of deaths. Therefore, although it is interesting to 
note that only one death was attributed to diabetes in those with youth-onset type 2 diabetes, 
we were unable to determine whether this is related to socioeconomic, psychosocial or other 
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risk factors of acute deaths. The mortality estimates for youth-onset type 2 diabetes are 
based on a very small number of deaths over a very short time period and may not reflect the 
true mortality rates across the US. In addition, we could not ascertain vital status for 9.3% of 
the cohort. These individuals were older at diabetes diagnosis, more likely to have type 2 
diabetes and to be non-Hispanic black; therefore, it is possible that our mortality findings are 
underestimated in these populations and the SMRs are higher than reported here. Further, we 
were unable to confirm cause of death through medical record review or death certificates. 
However, previous studies have demonstrated that the NDI is an accurate source for 
ascertaining vital status even in the absence of social security numbers. Sensitivity of the 
NDI ranges from 87% to 98% 28 and use of different combinations of personal identifiers 
can correctly identify 83% to 92% of decedents and 92% to 99% of living individuals.29 
Strengths of our study include the large sample size and racial/ethnic and geographic 
diversity, which makes our findings generalizable, although not necessarily generalizable to 
the entire US. Moreover, SEARCH is a unique and valuable resource for conducting 
mortality surveillance since it includes individuals with youth-onset type 1 and type 2 
diabetes. Few contemporary cohorts of incident type 1 and type 2 diabetes in children and 
young adults in the US are available; therefore, these results likely provide the most 
comprehensive and current estimates of the mortality experience of youth-onset diabetes in 
the US.
6. Conclusions
Among individuals with type 1 or type 2 diabetes, our results show excess short-term 
mortality risk in individuals with type 2 diabetes, non-Hispanic blacks, females and those 
aged 15–19 years compared to youth of similar age, sex, and race in the corresponding US 
states. We did not observe excess mortality in individuals with type 1 diabetes. Our findings 
begin to shed light on the epidemiology of short-term risk of mortality of youth-onset type 1 
and type 2 diabetes in the US. A longer follow-up in this well-characterized and 
contemporary cohort would allow for further examination of cause-specific mortality 
outcomes, which could help in developing focused strategies aimed to increase survival in 
youth-onset diabetes.
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Figure 1. 
Age-, Sex-, and Race-Standardized Mortality Ratios Overall and by Diabetes Type, Sex, 
Race/Ethnicity, and Age at Death or End of Follow-up
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Table 1
Characteristics of the 8,358 Diabetes Cases in the SEARCH for Diabetes in Youth Study, Overall and by Type, 
2002–2008
Characteristics Total (N=8,358)
Diabetes Type
Type 1 (N=6,840) Type 2 (N=1,518)
Age at diabetes diagnosis (years) 10.7±4.7 9.8±4.5 14.7±2.8
Age group at diagnosis (years), N (%)
 0–4 1228 (14.7) 1224 (17.9) 4 (0.3)
 5–9 2221 (26.6) 2155 (31.5) 66 (4.3)
 10–14 3230 (38.6) 2517 (36.8) 713 (47.0)
 15–19 1679 (20.1) 944 (13.8) 735 (48.4)
Sex, N (%)
 Female 4186 (50.1) 3278 (47.9) 908 (59.8)
 Male 4172 (49.9) 3562 (52.1) 610 (40.2)
Race/Ethnicity, N (%)
 Non-Hispanic White 5132 (61.4) 4812 (70.4) 320 (21.1)
 Non-Hispanic Black 1296 (15.5) 781 (11.4) 515 (33.9)
 Hispanic 1360 (16.3) 908 (13.3) 452 (29.8)
 Other/Unknown 570 (6.8) 339 (5.0) 231 (15.2)
Year of diagnosis, N (%)
 2002 1132 (13.5) 924 (13.5) 208 (13.7)
 2003 1087 (13.0) 888 (13.0) 199 (13.1)
 2004 1102 (13.2) 910 (13.3) 192 (12.6)
 2005 1196 (14.3) 990 (14.5) 206 (13.6)
 2006 1249 (14.9) 1021 (14.9) 228 (15.0)
 2007 1286 (15.4) 1047 (15.3) 239 (15.7)
 2008 1306 (15.6) 1060 (15.5) 246 (16.2)
Follow-up time from diagnosis, years* 5.3 (0–9) 5.3 (0–9) 5.2 (0–9)
Age at death/censor (years) 16.0±5.0 15.2± 4.9 20.0±3.5
Age group at death/censor (years), N (%)
 < 14 3449 (41.3) 3328 (48.6) 121 (8.0)
 15–19 2904 (34.7) 2295 (33.6) 609 (40.1)
 20–24 1795 (21.5) 1121 (16.4) 674 (44.4)
 25–29 210 (2.5) 96 (1.4) 114 (7.5)
Data are means ± standard deviation, N (%), or median (range), as appropriate.
*
Time is from diabetes diagnosis to death or censoring on 12/31/2010.
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Table 3
Underlying and Contributing Cause of Death by Diabetes Type among 8,358 Diabetes Cases in the SEARCH 
for Diabetes in Youth Study, 2002–2008
Cause of Death ICD-10 Code Total No. (%)
Type 1 Diabetes No. 
(%)
Type 2 Diabetes No. 
(%)
Total number of deaths 41 (100.0) 26 (63.4) 15 (36.6)
Underlying cause of death
 Infection and parasitic disease A00-B99 1 (2.4) 0 1 (6.7)
 Diseases of the blood D50-D89 1 (2.4) 0 1 (6.7)
 Endocrine, nutritional and metabolic diseases
  Diabetes mellitus (DM) E00-E69 12 (29.3) 11 (42.3) 1 (6.7)
  Insulin-dependent DM, with ketoacidosis E10.1 2 2 0
  Insulin-dependent DM, without complications E10.9 1 1 0
  Unspecified DM, with coma E14.0 1 0 1
  Unspecified DM, with ketoacidosis E14.1 6 6 0
  Unspecified DM, without complications E14.9 2 2 0
 Metabolic disorders E70-E89 1 (2.4) 1 (3.8) 0
 Mental and behavioral disorders F01-F99 1 (2.4) 0 1 (6.7)
 Diseases of the nervous system G00-G98 3 (7.3) 2 (7.7) 1 (6.7)
 Diseases of the circulatory system I00-I99 2 (4.9) 1 (3.8) 1 (6.7)
 Diseases of the respiratory system J00-J98 2 (4.9) 2 (7.7) 0
 Diseases of the digestive system K00-K92 0 0 0
 Pregnancy, childbirth and puerperium O00-O99 0 0 0
  Congenital malformations Q00-Q99 0 0 0
  External causes of morbidity and  mortality V00-Y89
  Transport/motor vehicle accidents V13-V89 5 (12.2) 2 (7.7) 3 (20.0)
 Other external causes of accidental injury W00-X59 3 (7.3) 3 (11.5) 0
 Accidental poisoning X40-X49 2 (4.9) 0 2 (13.3)
 Intentional self-harm X60-X84 5 (12.2) 3 (11.5) 2 (13.3)
 Sequelae of motor vehicle accident Y85 1 (2.4) 0 1 (6.7)
Unknown 2 (4.9) 1 (3.8) 1 (6.7)
Contributing cause of death
 Diabetes E10-E14 2 (4.9) 2 (7.7) 0
Underlying or contributing cause of death*
 Diabetes E10-E14 14 (34.1) 13 (50.0) 1 (6.7)
*Underlying cause of death when diabetes mellitus is a contributing cause: Other external causes of accidental injury and Transport/motor vehicle 
accident
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